GlassScriptPhysician profile
Brent Whitehead
NPI 1437738341
$4,926.46
in general payments reported to CMS, 2019-2025
9 companies · $2,051 in 2025
The $2,051 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,549 · 2023: $475 · 2024: $851 · 2025: $2,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,527 · Travel and Lodging: $599 · Education: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,527.48 |
| Travel and Lodging | $598.72 |
| Education | $250.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,881.11 | 2022-2025 | Pro, Mako, T2 Alpha |
| Mid-Atlantic Surgical Systems, LLC | $1,385.53 | 2022-2025 | |
| Depuy Synthes Sales INC. | $323.79 | 2025 | Na, Motoband, Va-Lcp |
| Becton, Dickinson and Company | $140.54 | 2022 | |
| Si-Bone, INC. | $70.42 | 2024 | |
| Ethicon US, LLC | $51.94 | 2024 | Ethicon, Vistaseal |
| Innovation Technologies INC | $39.57 | 2025 | Irrisept |
| Organogenesis INC. | $17.79 | 2025 | Puraply Wound Matrix |
| Kci USA, INC. | $15.77 | 2023 | V.A.C. Veraflo, Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Whitehead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.